US FDA needs more time on Juul e-cigarettes decision
The U.S. Food and Drug Administration is expected to ask for more time before deciding whether e-cigarettes from market leader Juul Labs Inc can be sold in the United States, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
Juul, along with other e-cigarette brands including British American Tobacco Plc’s Vuse and Imperial Brands Plc’s Blu, had to meet a September 2020 deadline to file applications to the FDA showing that its products provided a net benefit to public health.
The agency had a year to judge whether each product was effective in getting smokers to quit and, if so, whether the benefits to smokers outweighed the health damage to new e-cigarette users – including teenagers – who never smoked.
The FDA and Juul did not immediately respond to Reuters’ requests for comment.
— Senator Dick Durbin (@SenatorDurbin) June 30, 2021
In August, the agency denied marketing applications for nearly 55,000 flavored e-cigarette products from three tiny companies for failing to provide evidence they appropriately protect public health.
The agency said last month it received applications from over 500 companies covering more than 6.5 million tobacco products.
E-cigarettes have operated in a regulatory gray area for years. The products, which vaporize a nicotine-laced liquid, have been available in the United States since at least 2007, but the FDA did not formally get jurisdiction over the industry until May 2016.
During that time, Juul and dozens of competitors introduced products that were grandfathered into the market because they were already being sold before the regulation took effect.
A Reuters investigation in 2019 detailed how Juul’s developers used tobacco industry research and patents to formulate a smooth but potent blend of liquid nicotine that became a key factor in its popularity among teenagers.
Facing a backlash from parents, teachers and regulators, including state attorneys general, Juul stopped selling its popular fruit- and mint-flavored nicotine pods in 2019, ahead of an FDA ban on such flavors in early 2020.
(Reporting by Ankur Banerjee in Bengaluru and Chris Kirkham in Los Angeles ; Editing by Bill Berkrot and Anil D’Silva)